Next Article in Journal
Dual-Energy Computed Tomography Applications to Reduce Metal Artifacts in Hip Prostheses: A Phantom Study
Next Article in Special Issue
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction
Previous Article in Journal
A Pain in the Neck: Lessons Learnt from Genetic Testing in Fetuses Detected with Nuchal Fluid Collections, Increased Nuchal Translucency versus Cystic Hygroma—Systematic Review of the Literature, Meta-Analysis and Case Series
Previous Article in Special Issue
Safe Follow-Up after Endovascular Aortic Repair with Unenhanced MRI: The SAFEVAR Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression

1
RoNeuro Institute for Neurological Research and Diagnostic, 400364 Cluj-Napoca, Romania
2
Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, 400083 Cluj-Napoca, Romania
3
Department of Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
4
Faculty of Medicine, Ovidius University, 900527 Constanta, Romania
5
Department of Public Health, Babes-Bolyai University, 400294 Cluj-Napoca, Romania
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(1), 49; https://doi.org/10.3390/diagnostics13010049
Submission received: 7 November 2022 / Revised: 14 December 2022 / Accepted: 22 December 2022 / Published: 23 December 2022
(This article belongs to the Collection Vascular Diseases Diagnostics)

Abstract

:
Introduction: Post-stroke depression (PSD) has complex pathophysiology determined by various biological and psychological factors. Although it is a long-term complication of stroke, PSD is often underdiagnosed. Given the diagnostic role of quantitative electroencephalography (qEEG) in depression, it was investigated whether a possible marker of PSD could be identified by observing the evolution of the (Delta + Theta)/(Alpha + Beta) Ratio (DTABR), respectively the Delta/Alpha Ratio (DAR) values in post-stroke depressed patients (evaluated through the HADS-D subscale). Methods: The current paper analyzed the data of 57 patients initially selected from a randomized control trial (RCT) that assessed the role of N-Pep 12 in stroke rehabilitation. EEG recordings from the original trial database were analyzed using signal processing techniques, respecting the conditions (eyes open, eyes closed), and several cognitive tasks. Results: We observed two significant associations between the DTABR values and the HADS-D scores of post-stroke depressed patients for each of the two visits (V1 and V2) of the N-Pep 12 trial. We recorded the relationships in the Global (V1 = 30 to 120 days after stroke) and Frontal Extended (V2 = 90 days after stroke) regions during cognitive tasks that trained attention and working memory. For the second visit, the association between the analyzed variables was negative. Conclusions: As both our relationships were described during the cognitive condition, we can state that the neural networks involved in processing attention and working memory might go through a reorganization process one to four months after the stroke onset. After a period longer than six months, the process could localize itself at the level of frontal regions, highlighting a possible divergence between the local frontal dynamics and the subjective well-being of stroke survivors. QEEG parameters linked to stroke progression evolution (like DAR or DTABR) can facilitate the identification of the most common neuropsychiatric complication in stroke survivors.

1. Introduction

Stroke is the second most common cause of death in individuals over 60 and the fifth major cause of mortality in people aged 15 to 59 [1]. Regarding stroke impairment, neuropsychiatric conditions are the most prevalent category among survivors. They are linked to poorer functional outcomes, decreased treatment adherence, and an increased caregiver burden [2]. Being associated with delayed recovery and increased mortality, complications like post-stroke depression (PSD) negatively impact the life quality of stroke survivors [3,4,5].
Despite being a common and long-term complication of ischemic stroke, PSD often remains underdiagnosed. Its prevalence can vary considerably, with several reports illustrating the range between 11–61% and a peak between three and six months after the ischemic event [6,7,8,9]. The link between stroke and depression has been researched for many years, demonstrating that depressive symptoms were significantly more common in patients with motor dysfunctions after ischemic events than in patients with similar physical impairments [7,10].
The Hospital Anxiety and Depression Scale (HADS) is a clinical tool consisting of 14 questions equally divided into two subscales (HADS-A for grading anxiety and HADS-D for grading depression). The HADS-S subscale has been previously used to assess PSD in several studies [4,5,11].
Processing cerebral signals by mathematical and statistical algorithms are the appanage of quantitative EEG (qEEG). Performing computations of the recorded signals can bring valuable information regarding frequency (shifting from the time domain through the Fourier Transform–FT), power spectrum density, or the connections between various brain regions (connectivity) [12].
Due to its highly accurate temporal resolution, qEEG can observe changes in the cerebral activity of patients with depression. The decline in the prefrontal region and the absence of symmetrical discharges of the combined power of alpha and theta waves were the most reliable qEEG markers observed [13,14,15]. Although specific studies have highlighted the role of qEEG in the follow-up of neuropsychiatric complications, it has not been previously used to assess PSD [16,17].
Specific qEEG ratios, like the (delta + theta)/(alpha + beta) ratio (DTABR) or the delta/alpha ratio (DAR), can help observe the evolution of ischemic stroke patients, especially in the subacute period [18,19,20]. Moreover, both DAR and DTABR can deliver meaningful information regarding the outcome of patients after an ischemic stroke [21,22,23].
The primary objective of the current paper was to describe a possible marker of PSD by analyzing the DAR and DRABR values in PSD patients (evaluated through the HADS-D subscale), additionally observing the accuracy of the subscale in the diagnosis of PSD. The data was extracted from a randomized control trial, which assessed the role of the dietary supplement N-Pep-12 in the neuro recovery of stroke by multiple outcome scales [24], as well as from a secondary data analysis of the mentioned trial [25].

2. Materials and Methods

2.1. Study Design, Population, and Procedures

The N-Pep 12 trial by Balea et al. is a prospective, double-blind, randomized controlled trial that focused on the role of N-Pep-12 (Cebrium®) in the neurorehabilitation of stroke survivors with cognitive disorders. It involved a multivariate approach, selecting five neuropsychological instruments for evaluating the subjects: The Montreal Cognitive Assessment, Color Trails Test—A & B, Processing Speed Index—Digit Symbol Coding and Symbol Search, Digit Span Forward and Backwards, as well as the HAD Scale [24].
The population described in the present study included 57 subjects from the RCT by Balea et al. (39 of the intervention group and 18 controls), assessed through qEEG algorithms in a 2021 secondary data analysis. In addition, demographics, medical history, EEG recordings, depression scores graded by the HADS-D subscale, and the qEEG values were collected for the current study from the same RCT and secondary analysis to identify a possible PSD biomarker [24,25].
All patients were selected based on the inclusion criteria of the original RCT [24]: the window of admission (between one to four months after the ischemic event), type of stroke (ischemic lesion), localization (supratentorial CT or MRI-established lesion), and no previous clinical and radiological signs of brain ischemia. The absence of disability before the onset (certified by a score of 0 or 1 on the Modified Rankin Scale) was considered a criterion of eligibility. The National Institutes of Health Stroke Scale (NIHSS) was selected for evaluating stroke severity.

2.2. EEG Signal Acquisition, Preprocessing, and Analysis

Brain signals were recorded during both resting and cognitive conditions during the N-Pep-12 trial. The International 10-10 system for electrode placement was selected, using the Nicolet® 32-channel Amplifier to register the EEG activity [24].
The cognitive conditions consisted of three neuropsychological tasks: RTI—Reaction Time Index (COG1), OTS—One Touch Stockings (COG2), and PAL—Period Associated Learning (COG3). The patient had access to a tablet to solve the cognitive tasks. The first task (RTI) assessed patients’ reaction time, processing, and psychomotor speed. The capacity of working memory, planning, and other executive functions (e.g., attention) was the subject of analysis for the second cognitive exercise (OTS). The final task (PAL) was used to test the capacity of subjects to learn novel notions. All three tasks are part of CANTAB (Cambridge Neuropsychological Test Automated Battery—Cambridge Cognition®) and were used to observe changes in the EEG traces while the patients train specific functions of the frontal and temporal lobes.
Four different regions of interest (ROIs) were created per the brain areas assessed by cognitive tasks (Global—comprising all electrodes, Frontal Standard—4 electrodes, Frontal Extended—expanding the previous group to the two frontopolar electrodes, Temporo-Parietal—7 electrodes, of which P7 and P8 are considered an equivalent of T5, respectively T6) (Figure 1).
The following EEG sequence was recorded and selected for our analysis (1) Eyes open (EO1) for 5 min; (2) Eyes closed (EC1) for 5 min, (3) Cognitive tasks (COG1—RTI; COG2—OTS; COG3—PAL) for 10 min altogether (4) Eyes open (EO2) for 5 min and (5) Eyes closed (EC2) for 5 min.
The EEG data were preprocessed and analyzed using the BrainVision Analyzer (BVA) version 2.1 software (Brain Products GmbH, Gilching, Germany). Establishing the position for the 32 channels was the first step of data preprocessing, each channel being virtually placed on a 2D circular map based on the values of three parameters (radius, theta, and pi). The sampling rate (the number of times the data is collected from all the available electrodes per second) was downsized to 512 Hz from 1024 Hz. Semi-automatic Raw Data Inspection (RDI) was used to eliminate large-scale artifacts, marking an area for rejection around the artifact that starts 0.2 s before the unwanted portion and ends 0.2 s after [25].
Low-pass and high-pass filter values (0.5, respectively, 40 Hz) were selected. The notch filter was also set at 50 Hz. The continuous EEG recordings were segmented using start and end markers, recreating the original seven segments—EO1 & EC1, COG1, COG2, and COG3, and EO2 & EC2, respectively.
Semi-automatic Independent Component Analysis (ICA) was computed on all seven conditions. ICA components with kurtosis and energy values higher than 3, respectively 2, were not considered viable, as the majority of artifact segments (e.g., electrode, pop-up, salt-bridge, or gross muscular artifacts) are located above these values. A second segmentation process was applied, sorting the data into epochs of 2 s. Frequency-domain analysis was performed using the Fast-Fourier transform (FFT).
An average of the absolute power (AP for all three conditions (resting state—eyes open, resting state—eyes closed, and cognitive tasks) was computed for all 32 electrodes. The absolute power was calculated for the following power bands: δ (0.5–4 Hz), θ (4–8 Hz), α (8–13 Hz) and, β (13–30 Hz). Therefore, two ratios were determined:
DTABR (Delta Theta/Alpha Beta Ratio) = (δ + θ)/(α + β)
DAR (Delta Alpha Ratio) = δ/α
All statistical tests were two-sided. The descriptive statistics were performed using SPSS® Statistics v25 (IBM®, Armonk, New York, USA). Pearson’s correlation was performed to determine the association between the HADS-D scores and the AP values in the frequency bands and ratios mentioned above.

3. Results

Out of 57 patients, the proportion of male subjects was 82.5%. As shown in Table 1, the most prevalent type of ischemic stroke (TOAST classification) was thrombotic (80.7%), followed by cardioembolic (15.8%) and lacunar (3.5%). Regarding stroke severity, 54.4% of the cases were moderate ischemic strokes (NIHSS between 5 and 12 points). Table 1 also presents data on the vascular territory in which the stroke occurred [25].
Table 2 presents the frequency of depressive symptoms graded through the HADS-D subscale. The majority of patients had no depressive symptoms during either visit (66.7% and 75.4%), with only one patient diagnosed with severe depression (V1) [25].
One direct association stood out during the reinterpretation of the V1 results (Baseline—90 to 120 days after stroke onset), linking the level of depression scored on the HADS-D test and the DTAB Ratio value (Table 3). In addition, the association is observed globally (across all 32 electrodes) during the second and third cognitive tasks.
A second significant association involving the DTABR values and the HADS-D scores was identified for the second visit during the second and third cognitive tasks (Table 4). This finding was identified in the Frontal Extended region as a negative correlation.
No statistically significant association was found at any of the time points (V1 and V2) for the first cognitive task (COG1) in either of the two regions mentioned above (Table 5).
The analysis for both time points (V1 and V2) produced no any additional significant correlations for neither ratio (DTABR or DAR).
As significant results were found only in the Global and Frontal Extended regions, Table 6 presents the DTABR scores calculated from the averaged AP values. The AP was computed for the delta, theta, alpha and beta frequency bands at each visit (V1 and V2) for all cognitive task conditions (COG1, COG2, and COG3).

4. Discussion

The current study aimed to explore a possible PSD marker by looking at the behavior of two qEEG parameters (DTABR and DAR) in a population of stroke survivors graded for depression using the HADS-D subscale [24,25].
Almost four decades ago, it was first described that delta activity registers a peak throughout the infarcted area in relationship with the reduction of blood supply in that region. Previous studies discovered that before an increase in delta activity can be recognized, the general attenuation of both alpha and beta waves might be observed. Therefore, the DTABR can be summarized as a predominance of slow frequencies (delta or/and theta) over fast ones (alpha or/and beta). If the values of the ratio increase over time, the overall prognostic can be considered unfavorable [26,27,28].
A study by Finnigan et al. [17] observed changes in the delta frequency band (AP values) for acute stroke patients that varied with time. A significant association between the NIHS Scale and delta activity 30 days after stroke onset was validated for is chemic stroke survivors [17]. Moreover, a paper by Burghaus et al. [29] demonstrated the widespread presence of delta activity paired with a decrease in the alpha frequency band for patients with malignant evolution after brain ischemia (e.g., massive cerebral edema). Regarding mild and moderate strokes (NIHSS between 0–12), the absence of delta waves and predominance of fast frequencies (e.g., beta) translated to a more favorable outcome [29].
The literature regarding PSD evaluation through EEG techniques is relatively scarce, with contrasting results between studies. As PSD subjects exhibit increased power in the delta and theta bands, elevated alpha and beta activity were found in patients without PSD, translated as a decreased general slowing and decreased DTABR values [30]. One study highlighted the predominance of alpha and theta activity specifically in PSD patients [31], alongside other papers that observed that greater levels of alpha power in the left frontal region could be associated with depressive symptoms and an elevated tendency toward general depression [30,32].
While the positive correlation was identified during V1 (one to four months after the stroke), finding a negatively correlated relation during follow-up (90 days after the first assessment) in one single ROI (Frontal Extended) could orientate us towards the reorganization of the communication between the lesionated area and the other cortical regions [33].
A study by Veer et al. [34], which explored the functional connectivity (FC) of the whole brain in patients with major depression during resting state, found changes in the FC in the left frontal region, part of a neural network implied in attention and working memory. Moreover, areas of the same network were found to be activated during any action that would require cognitive effort [34].
The second cognitive task (OTS—One Touch Stockings) evaluated attention and working memory as executive processes. As both identified relationships were significant during the cognitive condition, in which the network system described by Veer et al. would express high levels of activity, an inceptive reorganizational phase of the neuronal activity could be observed at V1. In the end, the process could localize itself in the frontal part of the brain at V2 (the period between the two visits being three months) [35].
A 2015 paper by Zheng et al. [31] assessed neural complexity (the level of complexity of a specific neural system) between ischemic stroke survivors with PSD, without PSD, and controls. The study used the Lempel-Ziv Complexity (LZC) to evaluate changes in the recordings of the three groups. A decreased neural complexity was observed in PSD patients, especially in the frontal and temporal regions of stroke survivors with increased severity of PSD. In addition, the presence of slow waves (especially theta) was reported [31].
A divergence between the local frontal dynamics and the actual status of stroke survivors could arise. Although the HADS-D scale is a simple and facile way of grading depression, our findings could suggest a decreased accuracy for identifying symptoms in PSD patients. While the patient could be categorized as without depressive symptoms, a localized slowing in the frontal brain area should be observed through an elevated DTAB ratio. The possible misdiagnosing through the appliance of the HADS-D subscale could contribute to the uncertainty wandering around ischemic-related neuropsychiatric conditions.
Considering the different conditions during which data was acquired (eyes open, eyes closed, and cognitive tasks), our study’s methodology is distinguished within the available literature. However, several limitations can be pointed out, including the descriptive nature of the study, the number of analyzed subjects, and the reduced number of patients diagnosed with depression.

5. Conclusions

To our knowledge, no previous studies investigating the value of qEEG ratios (DAR and DTABR) in PSD were identified. The present article could aid the establishment of qEEG as a technique for diagnosing PSD in the future. Regardless of its pure descriptive nature, the current study could provide valuable information on the relationship between the frequency bands in the power spectrum. Furthermore, DTABR could be used to assess the predominance of either slow or fast waves in ischemic stroke patients.
While the HADS-D subscale is a general approach for measuring depression, it is unwise to consider it a standard in diagnosing PSD. As our results show, most of the patients evaluated through HADS-D were described as depression free. Additional research on the role of DTABR and other qEEG parameters in PSD is recommended, using RCT designs to encompass larger populations.
The absence of a standardized assessment to assess PSD and the scarce and contrasting literature on the subject are the reasons why our attention should focus on identifying a marker for the condition. While qEEG is not as prevalent as other investigations from the field of neurology, the method could help diagnose post-stroke neuropsychiatric comorbidities in the future.

Author Contributions

Conceptualization: D.C., L.L.P. and V.D., methodology: D.C., L.L.P. and V.D., software: D.C., validation: Ș.S. and C.D., investigation: V.D., resources: D.F.M., data curation: E.H., writing—original draft preparation: D.C. and V.D., writing—review and editing: L.L.P., D.C. and V.D., visualization: D.C., supervision: R.C. and Ș.S. and project administration: L.L.P. and B.O.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Johnson, W.; Onuma, O.; Owolabi, M.; Sachdev, S. Stroke: A Global Response Is Needed. Bull. World Health Organ. 2016, 94, 634–634A. [Google Scholar] [CrossRef] [PubMed]
  2. Stein, L.A.; Goldmann, E.; Zamzam, A.; Luciano, J.M.; Messé, S.R.; Cucchiara, B.L.; Kasner, S.E.; Mullen, M.T. Association Between Anxiety, Depression, and Post-Traumatic Stress Disorder and Outcomes After Ischemic Stroke. Front. Neurol. 2018, 9, 890. [Google Scholar] [CrossRef] [PubMed]
  3. Khedr, E.M.; Abdelrahman, A.A.; Desoky, T.; Zaki, A.F.; Gamea, A. Post-Stroke Depression: Frequency, Risk Factors, and Impact on Quality of Life among 103 Stroke Patients—Hospital-Based Study. Egypt. J. Neurol. Psychiatry Neurosurg. 2020, 56, 66. [Google Scholar] [CrossRef]
  4. Stern, A.F. The Hospital Anxiety and Depression Scale. Occup. Med. 2014, 64, 393–394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Ayis, S.A.; Ayerbe, L.; Ashworth, M.; DA Wolfe, C. Evaluation of the Hospital Anxiety and Depression Scale (HADS) in Screening Stroke Patients for Symptoms: Item Response Theory (IRT) Analysis. J. Affect. Disord. 2018, 228, 33–40. [Google Scholar] [CrossRef] [Green Version]
  6. Towfighi, A.; Ovbiagele, B.; El Husseini, N.; Hackett, M.L.; Jorge, R.E.; Kissela, B.M.; Mitchell, P.H.; Skolarus, L.E.; Whooley, M.A.; Williams, L.S. Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2017, 48, e30–e43. [Google Scholar] [CrossRef]
  7. Roth, M. The Natural History of Mental Disorder in Old Age. J. Ment. Sci. 1955, 101, 281–301. [Google Scholar] [CrossRef]
  8. Barkercollo, S. Depression and Anxiety 3 Months Post Stroke: Prevalence and Correlates. Arch. Clin. Neuropsychol. 2007, 22, 519–531. [Google Scholar] [CrossRef] [Green Version]
  9. Townend, B.S.; Whyte, S.; Desborough, T.; Crimmins, D.; Markus, R.; Levi, C.; Sturm, J.W. Longitudinal Prevalence and Determinants of Early Mood Disorder Post-Stroke. J. Clin. Neurosci. 2007, 14, 429–434. [Google Scholar] [CrossRef]
  10. Folstein, M.F.; Maiberger, R.; McHugh, P.R. Mood Disorder as a Specific Complication of Stroke. J. Neurol. Neurosurg. Psychiatry 1977, 40, 1018–1020. [Google Scholar] [CrossRef]
  11. Tang, W.K.; Wong, E.; Chiu, H.F.K.; Ungvari, G.S. Rasch Analysis of the Scoring Scheme of the HADS Depression Subscale in Chinese Stroke Patients. Psychiatry Res. 2007, 150, 97–103. [Google Scholar] [CrossRef]
  12. Wutzl, B.; Golaszewski, S.M.; Leibnitz, K.; Langthaler, P.B.; Kunz, A.B.; Leis, S.; Schwenker, K.; Thomschewski, A.; Bergmann, J.; Trinka, E. Narrative Review: Quantitative EEG in Disorders of Consciousness. Brain. Sci. 2021, 11, 697. [Google Scholar] [CrossRef]
  13. Wade, E.C.; Iosifescu, D.V. Using Electroencephalography for Treatment Guidance in Major Depressive Disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2016, 1, 411–422. [Google Scholar] [CrossRef]
  14. Bares, M.; Brunovsky, M.; Novak, T.; Kopecek, M.; Stopkova, P.; Sos, P.; Krajca, V.; Höschl, C. The Change of Prefrontal QEEG Theta Cordance as a Predictor of Response to Bupropion Treatment in Patients Who Had Failed to Respond to Previous Antidepressant Treatments. Eur. Neuropsychopharmacol. 2010, 20, 459–466. [Google Scholar] [CrossRef]
  15. de la Salle, S.; Jaworska, N.; Blier, P.; Smith, D.; Knott, V. Using Prefrontal and Midline Right Frontal EEG-Derived Theta Cordance and Depressive Symptoms to Predict the Differential Response or Remission to Antidepressant Treatment in Major Depressive Disorder. Psychiatry Res. Neuroimaging 2020, 302, 111109. [Google Scholar] [CrossRef]
  16. Finnigan, S.P.; Walsh, M.; Rose, S.E.; Chalk, J.B. Quantitative EEG Indices of Sub-Acute Ischaemic Stroke Correlate with Clinical Outcomes. Clin. Neurophysiol. 2007, 118, 2525–2532. [Google Scholar] [CrossRef]
  17. Finnigan, S.P.; Rose, S.E.; Walsh, M.; Griffin, M.; Janke, A.L.; McMahon, K.L.; Gillies, R.; Strudwick, M.W.; Pettigrew, C.M.; Semple, J.; et al. Correlation of Quantitative EEG in Acute Ischemic Stroke With 30-Day NIHSS Score. Stroke 2004, 35, 899–903. [Google Scholar] [CrossRef]
  18. Chen, S.-T.; Ku, L.-C.; Chen, S.-J.; Shen, T.-W. The Changes of QEEG Approximate Entropy during Test of Variables of Attention as a Predictor of Major Depressive Disorder. Brain Sci. 2020, 10, 828. [Google Scholar] [CrossRef]
  19. Livint Popa, L.; Dragos, H.; Pantelemon, C.; Rosu, O.V.; Strilciuc, S. The Role of Quantitative EEG in the Diagnosis of Neuropsychiatric Disorders. J. Med. Life 2020, 13, 8–15. [Google Scholar] [CrossRef]
  20. Finnigan, S.; van Putten, M.J.A.M. EEG in Ischaemic Stroke: Quantitative EEG Can Uniquely Inform (Sub-)Acute Prognoses and Clinical Management. Clin. Neurophysiol. 2013, 124, 10–19. [Google Scholar] [CrossRef]
  21. Finnigan, S.; Wong, A.; Read, S. Defining Abnormal Slow EEG Activity in Acute Ischaemic Stroke: Delta/Alpha Ratio as an Optimal QEEG Index. Clin. Neurophysiol. 2016, 127, 1452–1459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zakaria, H.; Valentine, O.; Mayza, A. Analysis of Quantitative EEG (QEEG) Parameters on the Effect of Transcranial Direct Current Stimulation (TDCS) on Post-Stroke Patients; AIP Publishing LLC: Depok, Indonesia, 2021; p. 050001. [Google Scholar]
  23. Schleiger, E.; Sheikh, N.; Rowland, T.; Wong, A.; Read, S.; Finnigan, S. Frontal EEG Delta/Alpha Ratio and Screening for Post-Stroke Cognitive Deficits: The Power of Four Electrodes. Int. J. Psychophysiol. 2014, 94, 19–24. [Google Scholar] [CrossRef] [PubMed]
  24. Balea, M.; Birle, C.; Costin, C.; Marton, J.; Muresanu, I.A.; Jemna, N.; Popa, L.L.; Slavoaca, D.; Rosu, O.V.; Stan, A.; et al. Effects of N-Pep-12 Dietary Supplementation on Neurorecovery after Ischemic Stroke. Neurol. Sci. 2021, 42, 2031–2037. [Google Scholar] [CrossRef] [PubMed]
  25. Popa, L.L.; Iancu, M.; Livint, G.; Balea, M.; Dina, C.; Vacaras, V.; Vladescu, C.; Balanescu, L.; Buzoianu, A.D.; Strilciuc, S.; et al. N-Pep-12 Supplementation after Ischemic Stroke Positively Impacts Frequency Domain QEEG. Neurol. Sci. 2021, 43, 1115–1125. [Google Scholar] [CrossRef] [PubMed]
  26. Jordan, K.G. Emergency EEG and Continuous EEG Monitoring in Acute Ischemic Stroke. J. Clin. Neurophysiol. 2004, 21, 341–352. [Google Scholar]
  27. Tolonen, U.; Sulg, I.A. Comparison of Quantitative EEG Parameters from Four Different Analysis Techniques in Evaluation of Relationships between EEG and CBF in Brain Infarction. Electroencephalogr. Clin. Neurophysiol. 1981, 51, 177–185. [Google Scholar] [CrossRef]
  28. Schleiger, E.; Wong, A.; Read, S.; Rowland, T.; Finnigan, S. Poststroke QEEG Informs Early Prognostication of Cognitive Impairment. Psychophysiology 2017, 54, 301–309. [Google Scholar] [CrossRef]
  29. Burghaus, L.; Hilker, R.; Dohmen, C.; Bosche, B.; Winhuisen, L.; Galldiks, N.; Szelies, B.; Heiss, W.-D. Early Electroencephalography in Acute Ischemic Stroke: Prediction of a Malignant Course? Clin. Neurol. Neurosurg. 2007, 109, 45–49. [Google Scholar] [CrossRef]
  30. Begić, D.; Popović-Knapić, V.; Grubišin, J.; Kosanović-Rajačić, B.; Filipčić, I.; Telarović, I.; Jakovljević, M. Quantitative Electroencephalography in Schizophrenia and Depression. Psychiatr. Danub. 2011, 23, 355–362. [Google Scholar]
  31. Zheng, Y.-P.; Wang, F.-X.; Zhao, D.-Q.; Wang, Y.-Q.; Zhao, Z.-W.; Wang, Z.-W.; Liu, J.; Wang, J.; Luan, P. Predictive Power of Abnormal Electroencephalogram for Post-Cerebral Infarction Depression. Neural. Regen. Res. 2018, 13, 304–308. [Google Scholar] [CrossRef]
  32. Davidson, R. Anterior Cerebral Asymmetry and the Nature of Emotion. Brain Cogn. 1992, 20, 125–151. [Google Scholar] [CrossRef]
  33. Carter, A.R.; Shulman, G.L.; Corbetta, M. Why Use a Connectivity-Based Approach to Study Stroke and Recovery of Function? NeuroImage 2012, 62, 2271–2280. [Google Scholar] [CrossRef]
  34. Veer, I.M.; Beckmann, C.F.; van Tol, M.-J.; Ferrarini, L.; Milles, J.; Veltman, D.J.; Aleman, A.; van Buchem, M.A.; van der Wee, N.J.; Rombouts, S.A.R.B. Whole Brain Resting-State Analysis Reveals Decreased Functional Connectivity in Major Depression. Front. Syst. Neurosci. 2010, 4, 41. [Google Scholar] [CrossRef] [Green Version]
  35. Corbetta, M.; Shulman, G.L. Control of Goal-Directed and Stimulus-Driven Attention in the Brain. Nat. Rev. Neurosci. 2002, 3, 201–215. [Google Scholar] [CrossRef]
Figure 1. The four Regions of Interest (ROIs)—General—All 32 electrodes; Frontal Standard—4 electrodes; Frontal Extended—6 electrodes; Temporo-Parietal—7 electrodes.
Figure 1. The four Regions of Interest (ROIs)—General—All 32 electrodes; Frontal Standard—4 electrodes; Frontal Extended—6 electrodes; Temporo-Parietal—7 electrodes.
Diagnostics 13 00049 g001
Table 1. Patients’ characteristics and demographics.
Table 1. Patients’ characteristics and demographics.
Demographic CategoriesFrequencyValid Percentage
Gender
Female1017.5%
Male4782.5%
Age group
37–602442.1%
61–793357.9%
Type of stroke
Thrombotic4680.7%
Lacunar23.5%
Cardioembolic915.8%
Stroke severity
Minor (NIHSS 1–4 points)2238.6%
Moderate (NIHSS 5–12 points)3154.4%
Mild to Severe (NIHSS 17–20 points)47.0%
Vascular Territory
Left Middle Cerebral Artery2849.1%
Right Middle Cerebral Artery2543.9%
Left Posterior Cerebral Artery35.3%
Right Posterior Cerebral Artery11.8%
Table 2. HADS-D Scores—depressive symptoms.
Table 2. HADS-D Scores—depressive symptoms.
VISIT 1VISIT 2
FrequencyPercentageFrequencyPercentage
No depressive symptoms (<7)3866.7%4375.4%
Mild (8–10)1322.8%1119.3%
Moderate (11–14)58.8%35.3%
Severe (15–21)11.8%00.0%
Table 3. Significant correlations at V1.
Table 3. Significant correlations at V1.
AnalysisTime
Point
RegionSub-TypeCorrelation CoefficientSignificance
DTABR COG HADS-DV1GlobalCOG20.2920.028
COG30.2020.027
Table 4. Significant correlations at V2.
Table 4. Significant correlations at V2.
AnalysisTime
Point
RegionSub-TypeCorrelation CoefficientSignificance
DTABR COG HADS-DV2Frontal ExtendedCOG2−2640.049
COG3−3920.003
Table 5. Non-significant correlations.
Table 5. Non-significant correlations.
AnalysisTime
Point
RegionSub-TypeCorrelation CoefficientSignificance
DTABR COG HADS-DV1GlobalCOG1−0020.988
V2Frontal Extended−1190.383
Table 6. DTAB Ratio Scores.
Table 6. DTAB Ratio Scores.
DTAB Ratio ScoresVisit 1Visit 2
COG1COG2COG3COG1COG2COG3
Global1.5161.5001.4401.5081.4681.432
Frontal Extended1.4951.4781.4251.4861.4691.418
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Livinț Popa, L.; Chira, D.; Dăbală, V.; Hapca, E.; Popescu, B.O.; Dina, C.; Cherecheș, R.; Strilciuc, Ș.; Mureșanu, D.F. Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression. Diagnostics 2023, 13, 49. https://doi.org/10.3390/diagnostics13010049

AMA Style

Livinț Popa L, Chira D, Dăbală V, Hapca E, Popescu BO, Dina C, Cherecheș R, Strilciuc Ș, Mureșanu DF. Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression. Diagnostics. 2023; 13(1):49. https://doi.org/10.3390/diagnostics13010049

Chicago/Turabian Style

Livinț Popa, Livia, Diana Chira, Victor Dăbală, Elian Hapca, Bogdan Ovidiu Popescu, Constantin Dina, Răzvan Cherecheș, Ștefan Strilciuc, and Dafin F. Mureșanu. 2023. "Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression" Diagnostics 13, no. 1: 49. https://doi.org/10.3390/diagnostics13010049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop